Home Newsfeeds Wells Fargo Downgrades Centennial Resource Dev to Underweight, Lowers Price Target to $11

Wells Fargo Downgrades Centennial Resource Dev to Underweight, Lowers Price Target to $11

Wells Fargo analyst Joseph McKay downgrades Centennial Resource Dev (NASDAQ:CDEV) from Equal-Weight to Underweight and lowers the price target from $12 to $11.

byBenzinga Newsdesk

July 11, 2022

1 minute read

Wells Fargo analyst Joseph McKay downgrades Centennial Resource Dev (NASDAQ:CDEV) from Equal-Weight to Underweight and lowers the price target from $12 to $11.

Bunge, Gilead Sciences And A Famous Chocolate Maker On CNBC’s ‘Final Trades’

By Priya Nigam

March 27, 8:34 AM

On CNBC’s "Halftime Report Final Trades," JP Morgan Private Bank’s Anastasia Amoroso said she is sticking with Invesco QQQ Tru

News

NBC News Correspondent Josh Lederman Tweets ‘Just In – President Biden Today Signed The NDAA, The White House Says, Which Includes The Vax Mandate Repeal For The Military’

By Benzinga Newsdesk

December 23, 11:39 AM

https://twitter.com/JoshNBCNews/status/1606312885961068555

SPY

Evaxion Partners With Pharmaceutical Company Afrigen Biologics To Develop Novel mRNA Vaccine Against Gonorrhea

By Benzinga Newsdesk

September 20, 8:26 AM

Partnership based on a highly protective vaccine candidate identified by Evaxion's EDEN™ platformThe collaboration will access mRNA technology from the WHO and Medicines Patent Pool's mRNA Vaccine Technology

EVAX

Aptinyx’s Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study

By Vandana Singh

August 12, 9:32 AM

Aptinyx Inc (NASDAQ: APTX) has announced results from a Phase 2b study evaluating the effects of NYX-2925 in patients with fibromyalgia, characterized by muscular or musculoskeletal pain with stiffness and localized tenderness at specific points.

APTX

Wells Fargo Downgrades Centennial Resource Dev to Underweight, Lowers Price Target to $11

Related Posts

Bunge, Gilead Sciences And A Famous Chocolate Maker On CNBC’s ‘Final Trades’

NBC News Correspondent Josh Lederman Tweets ‘Just In – President Biden Today Signed The NDAA, The White House Says, Which Includes The Vax Mandate Repeal For The Military’

Evaxion Partners With Pharmaceutical Company Afrigen Biologics To Develop Novel mRNA Vaccine Against Gonorrhea

Aptinyx’s Chronic Pain Candidate Fails To Top Placebo In Mid-Stage Study